Back to top
more

Intellia Therapeutics (NTLA)

(Delayed Data from NSDQ)

$15.67 USD

15.67
8,845,931

+0.47 (3.09%)

Updated Jun 18, 2026 03:59 PM ET

After-Market: $15.63 -0.04 (-0.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (153 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks News

Zacks Equity Research

Should You Invest in the ARK Innovation ETF (ARKK)?

Sector ETF report for ARKK

    Zacks Equity Research

    Zacks Investment Ideas feature highlights: CRISPR, Editas and Intellia

    Zacks Investment Ideas feature highlights: CRISPR, Editas and Intellia

      Kevin Cook headshot

      CRISPR Science and Stocks: Knowing Enough to Invest

      Can you learn enough about the science and the companies to invest with confidence?

        Zacks Equity Research

        Should You Invest in the ARK Innovation ETF (ARKK)?

        Sector ETF report for ARKK

          Zacks Equity Research

          Zacks Investment Ideas feature highlights: CRISPR, Intellia Therapeutics, Editas and Vertex

          Zacks Investment Ideas feature highlights: CRISPR, Intellia Therapeutics, Editas and Vertex

            David Borun headshot

            Should You Buy the Dip in CRISPR Therapeutics?

            A "Clinical Hold" from the FDA has the shares falling, but is it an opportunity to get in?

              Zacks Equity Research

              Vertex/CRISPR's Sickle Disease Candidate Put on Hold by FDA

              FDA places clinical hold on a Vertex (VRTX) and CRISPR Therapeutics' IND application for CTX001 for the treatment of sickle cell disease.

                David Borun headshot

                Is Genome Editing the Next Biotech Breakthrough?

                CRISPR technology is promising to be the foundation the treatment of 1000s of diseases

                  Sweta Killa headshot

                  Should You Invest in the ARK Innovation ETF (ARKK)?

                  Sector ETF report for ARKK

                    Zacks Equity Research

                    Zacks Investment Ideas feature highlights: Sarepta Therapeutics, bluebird bio, Editas Medicine, Align Technology and Intellia Therapeutics

                    Zacks Investment Ideas feature highlights: Sarepta Therapeutics, bluebird bio, Editas Medicine, Align Technology and Intellia Therapeutics